» Articles » PMID: 31439127

ASGE Guideline on Screening and Surveillance of Barrett's Esophagus

Citing Articles

Risk Factors for the Development of Barrett's Esophagus and Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Antonios K, Aintabi D, McNally P, Berinstein E, Dutta P, Sampson N Cancer Rep (Hoboken). 2025; 8(3):e70168.

PMID: 40040340 PMC: 11880629. DOI: 10.1002/cnr2.70168.


American Society for Gastrointestinal Endoscopy guideline on the diagnosis and management of GERD: methodology and review of evidence.

Desai M, Ruan W, Thosani N, Amaris M, Scott J, Saeed A VideoGIE. 2025; 10(2):81-137.

PMID: 40012897 PMC: 11852708. DOI: 10.1016/j.vgie.2024.10.001.


Identification of as a Potential Biomarker for Progression from Barrett's Esophagus to Esophageal Adenocarcinoma: A Comprehensive Bioinformatic Analysis.

Qureshi S, Abbasi W, Qureshi M, Jalil H, Quraishy M Diagnostics (Basel). 2025; 14(24.

PMID: 39767224 PMC: 11675858. DOI: 10.3390/diagnostics14242863.


Progression to cancer in patients with confirmed dysplasia compared to dysplasia downgraded to non-dysplastic metaplasia in Barrett's esophagus: a retrospective cohort study in Sweden.

Elbe P, Ost A, Mellbom L, Thorell A, Hakanson B, Klevebro F Clin Endosc. 2024; 57(6):768-774.

PMID: 39623933 PMC: 11637657. DOI: 10.5946/ce.2023.313.


Liquid biopsy to identify Barrett's oesophagus, dysplasia and oesophageal adenocarcinoma: the multicentre study.

Miyoshi J, Mannucci A, Scarpa M, Gao F, Toden S, Whitsett T Gut. 2024; 74(2):169-181.

PMID: 39562048 PMC: 11869464. DOI: 10.1136/gutjnl-2024-333364.